Opposite effects of training in rats with stable and progressive pulmonary hypertension by Handoko, M.L. et al.
Opposite Effects of Training in Rats With Stable and
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Background—Exercise training in pulmonary arterial hypertension (PH) is a promising adjunct to medical treatment.
However, it is still unclear whether training is beneficial for all PH patients. We hypothesized that right ventricular
adaptation plays a pivotal role in the response to training.
Methods and Results—Two different dosages of monocrotaline were used in rats to model stable PH with preserved
cardiac output and progressive PH developing right heart failure. Two weeks after injection, PH was confirmed by
echocardiography, and treadmill training was initiated. Rats were trained for 4 weeks unless manifest right heart failure
developed earlier. At the end of the study protocol, all rats were functionally assessed by endurance testing,
echocardiography, and invasive pressure measurements. Lungs and hearts were further analyzed in quantitative
histomorphologic analyses. In stable PH, exercise training was well tolerated and markedly increased exercise
endurance (from 253.9 to 623.9 minutes; P0.001). Moreover, capillary density increased significantly (from
1.210.12 to 1.510.07 capillaries per cardiomyocyte; P0.05). However, in progressive PH, exercise training
worsened survival (hazard ratio, 2.7; 95% confidence interval, 1.1 to 14.2) and increased pulmonary vascular
remodeling. In addition, training induced widespread leukocyte infiltration into the right ventricle (from 13514 to
27618 leukocytes per 1 mm2; P0.001).
Conclusions—In our rat model, exercise training was found to be beneficial in stable PH but detrimental in progressive
PH. Future studies are necessary to address the clinical implications of our findings. (Circulation. 2009;120:42-49.)
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Pulmonary arterial hypertension (PH) is characterized byprogressive pulmonary vascular remodeling, which im-
portantly increases right ventricular (RV) afterload, eventu-
ally leading to right heart failure and premature death.1
Traditionally, PH patients were advised to limit physical
activity because of risk of fatal cardiovascular compromise.2
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Recent developments, however, have challenged this
view.3 First, the prognosis of PH patients improved with the
introduction of various potent PH-specific medications in the
last decades.4 Second, several studies have demonstrated
beneficial effects of training in patients with chronic obstruc-
tive pulmonary disease and with congestive heart failure, and
training was beneficial even for the most severely affected
patients (GOLD IV, New York Heart Association class IV)
often suffering from secondary PH.5,6 Finally, in a recent
clinical trial of 30 stable PH patients under optimized medical
treatment, Mereles et al7 reported marked improvement in
exercise capacity and quality of life after exercise training.
Although training might be a promising adjunct to medical
treatment in PH, it remains to be elucidated whether exercise
training is beneficial for all PH patients and what its effect is
on RV function and remodeling. RV adaptation might be a
discriminating factor for responsiveness to training. During
exercise, pulmonary artery pressures and RV afterload in-
crease,8 resulting in a transient elevation of RV wall stress.
Although this is unknown for right heart failure, for left heart
failure, it has been demonstrated that even a temporary
elevation of wall stress can upregulate local proinflammatory
factors, leading to leukocyte infiltration into the myocardi-
um.9 We hypothesized that such a proinflammatory reaction
in the right ventricle might outweigh the positive effects of
exercise training, especially in the presence of RV maladap-
tation to pressure overload.
We therefore conducted an experimental study and as-
sessed the effects of exercise training in 2 phenotypes of PH,
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Hypertension
namely stable PH with a preserved cardiac output (CO) at rest
and progressive PH developing right heart failure. Using a
comprehensive set of physiological and pathological end
points, we documented beneficial effects in stable PH but
detrimental effects in progressive PH.
Methods
All experiments were approved by the institutional animal care and
use committee at the VU University.
Experimental PH
Male Wistar rats were used (56 in total; weight, 150 to 175 g; Harlan,
Horst, the Netherlands). PH was induced by a single subcutaneous
injection of monocrotaline (Sigma-Aldrich, Zwijndrecht, the Neth-
erlands) dissolved in sterile saline.
Monocrotaline 60 mg/kg body mass was used to model progres-
sive PH developing right heart failure (n18); with a dose of 40
mg/kg monocrotaline, stable PH with a preserved CO was mimicked
(n18).10,11 The control group was injected with saline only (n20).
Study Design and Training Program
The exercise program was adopted from a validated exercise
program for Wistar rats described by Fenning et al.12 In the first
week, all rats were accustomed to treadmill running; mild electric
stimulation was used to encourage the rats to run. Then, rats were
randomly assigned to any of the 3 experimental groups (control,
stable PH, or progressive PH) and injected accordingly with mono-
crotaline or saline (Figure 1). In the next 2 weeks, all rats were
placed on the treadmill for 1 minute a day (5 times a week at a
constant speed of 13.3 m/min with no slope). After these 2 weeks,
the rats were again randomly assigned to an exercise training
program (control-Ex, stable PH-Ex, or progressive PH-Ex; 5 times a
week for 30 minutes at 13.3 m/min with no slope) or the sedentary
group (control-Sed, stable PH-Sed, or progressive PH-Sed; 5 times a
week for 1 minute at 13.3 m/min with no slope). The level of training
represented moderate exercise intensity (50% V˙ O2max).13 Animals
were trained for a maximum of 4 weeks (from day 14 until day 42
after monocrotaline injection). Rats that developed manifest clinical
signs of right heart failure (defined as 5% loss of body mass a day
and/or respiratory distress, cyanosis, lethargy) were euthanized early,
in keeping with the protocol approved by the institutional animal
care committee. Manifest right heart failure was the survival end
point and recorded as an event in the survival analysis.14
Endurance Test
Endurance testing was performed only on rats that completed the
4-week exercise program.12 The treadmill was set at a constant speed
of 15 m/min and a slope of 20°. The time from start until exhaustion
was used as a measure for the exercise endurance of the rats.
Exhaustion was established when the rats accepted the electric
stimulus 3 consecutive times as opposed to running. The maximal
running time was 90 minutes, which was achieved by all control rats.
Hemodynamic Evaluation
Echocardiography
The rats were evaluated by echocardiography at baseline (just before
they received their injection), at the start of training, and at the end
of the study protocol (when manifest signs of right heart failure
developed or 42 days after monocrotaline injection). Transthoracic
echocardiographic measurements (ProSound SSD-4000 system
equipped with a 13-MHz linear transducer [UST-5542], Aloka,
Tokyo, Japan) were performed on anesthetized but spontaneously
breathing rats (isoflurane 2.0% in 1:1 O2/air mix; Pharmachemie,
Haarlem, the Netherlands) as described previously.15
Analyses were performed offline (Image-Arena 2.9.1, TomTec
Imaging Systems, Unterschleissheim/Munich, Germany). Measured
parameters for cardiac and RV function were Doppler-derived stroke
volume, CO, and tricuspid annular plane systolic excursion
(TAPSE). Parameters for RV remodeling were RV end-diastolic
diameter and RV wall thickness. Parameters for pulmonary vascular
remodeling were pulmonary artery acceleration time normalized for
cycle length and pulmonary vascular resistance (PVR).
Disease progression of PH during the period of exercise training was
expressed as percentage changes in hemodynamics over time, ie, change
in CO:CO[(COend of protocolCOstart of training)/COstart of training]100%/days
of training. Other parameters for disease progression (change in
stroke volume, TAPSE, etc) were calculated similarly. The nonin-
vasive estimations of RV systolic pressures, PVR, and RV wall stress
are described in the online-only Data Supplement.
Invasive RV Pressure Measurements
At the end of the study protocol, open-chest RV catheterization was
performed under general anesthesia in all animals (isoflurane 2.0%
in 1:1 O2/air mix) as described elsewhere.16 Before the procedure, the
rats were intubated (16-gauge Teflon tube) and attached to a
mechanical ventilator (Micro-Ventilator, UNO, Zevenaar, the Neth-
erlands; ventilator settings: breathing frequency, 80 breaths per
minute; pressures, 9/0 cm H2O; inspiratory/expiratory ratio, 1:1). The
right ventricle was approached via a lateral right thoracotomy
through the fifth intercostal space. RV pressures were recorded by
the use of a high-fidelity catheter tip transducer (Mikro-Tip SPR-
671, Millar Instruments, Houston, Tex). Analyses were performed
when steady state was reached over an interval of at least 10 seconds
and averaged.
Histology
After the final hemodynamic assessment, the rats were euthanized by
exsanguination (under isoflurane), and heart, lungs, and other major
organs were harvested. Lungs were weighed, and the airways of the
left lobe were subsequently filled with a 1:1 mixture of saline and
cryofixative (Tissue-Tek optical coherence tomography compound,
Sakura Fintek Europe, Zoeterwolde, the Netherlands) and snap-
frozen in liquid nitrogen. The right lobe was used to measure the
ratio of dry to wet lung mass. The heart was perfused, weighed,
dissected, and snap-frozen in liquid nitrogen.
Histomorphometric Analysis of Heart and Lungs
The determination of cardiomyocyte cross-sectional area, cardiac
fibrosis, and relative wall thickness of pulmonary arterioles (PAs) is
described in detail in the online-only Data Supplement.
Analysis of capillary density and cardiac inflammation was
performed with quantitative immunofluorescence microscopy.
Briefly, cardiac cryosections (5 m) were incubated for 60 minutes
with primary CD31 (1:35; sc-1506-R, Santa Cruz Biotechnology,
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Figure 1. Study design. The effect of exercise training was stud-
ied in 2 distinct phenotypes of established PH (stable and pro-
gressive PH). Start indicates the start of the exercise period (14
days after injection); End, end of the study protocol (when mani-
fest signs of right heart failure developed or 42 days after
monocrotaline injection); Echo, echocardiographic evaluation;
ET, endurance testing; and Cath, RV catheterization.
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Santa Cruz, Calif) and CD45 (1:25; sc-53045, Santa Cruz Biotech-
nology) antibodies for capillary density and leukocyte infiltrations,
respectively, followed by appropriate secondary antibody staining
and WGA (glycocalyx) and DAPI (nuclei) counterstaining. Image
acquisition was performed on a Marianas digital imaging microscopy
workstation (Intelligent Imaging Innovations, Denver, Colo). Slide-
Book imaging analysis software (SlideBook 4.2, Intelligent Imaging
Innovations) was used to quantify the images semiautomatically.
Capillary density was expressed as the number of capillaries per
cardiomyocyte or number of capillaries per section area, measured in
at least 3 randomly chosen areas per ventricle, where cardiomyocytes
were transversally sectioned.17 Leukocyte infiltration was expressed
as the number of positive CD45 nuclei per section area, measured
over at least 3 randomly chosen areas per ventricle.18
Statistical Analysis
All analyses were performed in a blinded fashion. All data were
verified for normal distribution. Data are presented as meanSEM,
and analyses were performed on all rats unless stated otherwise. A
value of P0.05 was considered significant.
Survival estimates were performed by Kaplan–Meier analyses,
with posthoc comparisons performed by the log-rank test. Hazard
ratios were calculated by the proportional-hazards model. For all
other in vivo data, 2-way ANOVA was used. The interaction
between PH status and training status was tested; subsequently,
Bonferroni posthoc tests were performed (training versus sedentary
in the 3 experimental groups). All reported probability values of
posthoc comparisons are Bonferroni corrected (SPSS 16.0 for Win-
dows, SPSS, Chicago Ill). For histological data, multilevel analysis was
used to correct for the nonindependence of successive measurements of
cross-sectional areas and PA wall thickness per animal (MLwiN
2.02.03, Center for Multilevel Modeling, Bristol, UK).19
The authors had full access to and take full responsibility for the
integrity of the data. All authors have read and agree to the
manuscript as written.
Results
Established PH at Start of Training
Estimated RV systolic pressure (using pulmonary artery
acceleration time normalized for cycle length) at the start of
training was elevated for stable PH and progressive PH
compared with control (estimated RV systolic pressure:
stable PH, 362.8 mm Hg; progressive PH, 483.5 mm Hg;
control, 262.3 mm Hg; P0.001; Table I of the online-only
Data Supplement). In addition, compared with control, PVR
for stable and progressive PH was higher. Together with the
rise in pulmonary pressures, a modest increase in RV wall
thickness was found, indicating mild RV hypertrophy at the
start of training. At this time point, there were no signs of
cardiac dysfunction or adverse remodeling measured by CO,
stroke volume, heart rate, TAPSE, or RV end-diastolic
diameter (Table I of the online-only Data Supplement).
Induction of Stable Versus Progressive PH by
Different Monocrotaline Dosages
Serial echocardiographic measurements revealed different
phenotypes of PH induced by monocrotaline 40 or 60 mg/kg
(Figure I of the online-only Data Supplement). In stable
PH-Sed (40 mg/kg monocrotaline, untrained rats), from day
14 after monocrotaline injection, there was no significant in-
crease in PVR, and resting CO was preserved (PVR
7.55.0%/d; CO0.740.81%/d; CO at end10910
mL/min). Nevertheless, some signs of RV dysfunction and
adverse remodeling were observed in stable PH-Sed at the end
of the study protocol (TAPSE: 2.90.3 mm for stable PH-Sed
versus 3.70.1 mm for control-Sed; RV end-diastolic diameter:
5.40.4 mm for stable PH-Sed versus 3.50.1 mm for control-
Sed; all P0.05). In progressive PH-Sed (60 mg/kg monocro-
taline, untrained rats), a rapid increase in PVR and a marked
decline in CO were seen (PVR114.1%/d; CO3.1
0.76%/d; CO at end699.7 mL/min; all P0.05 versus stable
PH-Sed).
Effects of Training on Disease Progression in
Stable Versus Progressive PH
Serial echocardiographic measurements were used to study
the effect of training on disease progression in control, stable
PH, and progressive PH. Figure 2 shows the evolution of the
various echocardiography-derived hemodynamic parameters
over time for the different experimental groups (for numerical
data, see Table II of the online-only Data Supplement). The
divergent effect of training on disease progression is espe-
cially evident for CO (Figure 2B). During the exercise period,
a steeper fall in CO was observed for progressive PH-Ex
compared with progressive PH-Sed, whereas CO was better
preserved in stable PH-Ex than stable PH-Sed.
Effects of Training on Survival and Endurance in
Stable Versus Progressive PH
The loss of body mass and decline in CO were closely
correlated (r0.74, P0.001), which verifies the clinical
criteria used for right heart failure. From these criteria, we
observed that exercise training decreased survival signifi-
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Figure 2. Opposite effects of training in stable vs progressive
PH were found for all important hemodynamic parameters for
disease progression (indicated by the slope of the connecting
lines from the start of training to the end of the study protocol).
All data are presented as meanSEM. P values represent the
interactive effect per individual parameter. Each line corre-
sponds with an experimental group (see bottom). Numerical
data at the start of training and on disease progression can be
found in Tables I and II of the online-only Data Supplement.
EDD indicates end-diastolic diameter.
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cantly in progressive PH (hazard ratio: progressive PH-Ex
versus progressive PH-Sed, 2.7; 95% confidence interval, 1.1
to 14.2). In stable PH-Sed, 1 rat prematurely developed right
heart failure; all rats in the stable PH-Ex and control groups
survived (Figure 3A).
At 4 weeks, training significantly improved exercise en-
durance by 2-fold in stable PH (endurance: 623.9 minutes
for stable PH-Ex versus 253.9 minutes for stable PH-Sed;
P0.001), whereas the opposite trend was observed in progres-
sive PH. A strong significant interaction between training status
and PH status was present (P0.001; Figure 3B). The opposite
effects of training on survival and endurance are in line with
previous findings on disease progression.
RV Catheterization at the End of the
Study Protocol
RV catheterization at the end of the study protocol confirmed
the PH status of monocrotaline-treated rats (Figure II of the
online-only Data Supplement). There was a strong monocro-
taline dose-dependent response at the end of the study
protocol (P0.001); RV systolic pressure at rest doubled in
stable PH and almost tripled in progressive PH compared with
control, and a similar pattern was seen for RV diastolic pres-
sures. In addition, the intrinsic RV contractility and relaxation
were significantly changed in stable and progressive PH com-
pared with control. However, no (statistical) differences in RV
dP/dtmax and RV dP/dtmin were found between the 2 PH
phenotypes. RV catheterization at the end of the study protocol
revealed no (interactive) effect of training.
Effects of Training on Pulmonary Vascular
Remodeling in Stable Versus Progressive PH
Training increased (wet) lung weights in progressive PH
(P0.001), whereas it had no effect on lung weights in stable
PH, independently of normalization (ie, normalization by body
mass or tibia length; Figure 4A, Table III of the online-only Data
Supplement). Moreover, a strong interaction between training
status and PH status was present (P0.001). Ratios of wet to dry
lung mass were similar for all experimental groups (ratios of
wet to dry lung mass between groups varied from 4.90.1 to
5.20.1; see Table III of the online-only Data Supplement).
This suggests that training modulated pulmonary vascular
remodeling and that the observed differences are not likely to
be attributed to pulmonary edema. Measurements of PA wall
thickness confirmed the interactive effect of training on
pulmonary vascular remodeling (Figure 4B). Echocardiogra-
phy-derived PVR at the end of the study protocol and PA wall
thickness correlated well (r0.82, P0.001), indicating that
the pulmonary vascular remodeling must have had profound
hemodynamic effects in vivo.
Effects of Training on Cardiac Remodeling in
Stable Versus Progressive PH
Histomorphology
In contrast with pulmonary vascular remodeling, the amount
of RV hypertrophy was similar among stable and progressive
PH, whether it was expressed by RV mass (normalized or
not) or RV/(LV	S), where LV is left ventricle and S is
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Figure 3. A, Training had a detrimental effect on survival in progressive PH, whereas it did not affect survival in stable PH. All rats from
the control groups survived and are omitted here for clarity. B, Training improved endurance 2-fold in stable PH, whereas an opposite
trend was observed in progressive PH (interactive effect, P0.001). All rats in the control groups reached the predefined maximum
endurance time (90 minutes; horizontal line). All data are presented as meanSEM. Endurance testing was performed only on surviving
rats, therefore n10 (control-Sed), n10 (control-Ex), n8 (stable PH-Sed), n9 (stable PH-Ex), n4 (progressive PH-Sed), and n1
(progressive PH-Ex). MCT indicates monocrotaline.
Figure 4. Training significantly worsened pulmonary vascular
remodeling in progressive PH, demonstrated by elevated (wet)
lung mass and increased PA wall thickness in progressive
PH-Ex vs progressive PH-Sed (P0.001). Moreover, significant
interactions between training status and PH status were present
(A and B; P0.001 for lung mass, P0.01 for PA wall thick-
ness). Bottom, Typical examples of PAs (elastica von Gieson,
200 magnification) of control-Sed (C) and progressive PH-Ex
(D). Data are presented as meanSEM.
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septum (Table III of the online-only Data Supplement),
confirming echocardiographic observations. Measurements
of RV cardiomyocyte cross-sectional area also showed sim-
ilar RV hypertrophy between stable and progressive PH
compared with control (Figure 5A). RV fibrosis was signif-
icantly increased in progressive PH only; no additional effect
of training was found (Figure 5B). Similar levels of RV
hypertrophy but differences in RV diameters (Figure 5C)
indicate concentric instead of eccentric remodeling, which
translated to severely elevated RV wall stress levels for
progressive PH but only moderately elevated wall stress
levels for stable PH; no interactive effect of training was
observed (Figure 5D).
Analyses of LV myocardium revealed atrophy (evident
from lower LV mass and lower LV cardiomyocyte cross-
sectional area) and increased fibrosis in progressive PH only. No
effect of training was observed on LV myocardium in progres-
sive PH (Figure III of the online-only Data Supplement).
Cardiac Capillarization and Inflammation
Training improved RV capillarization in stable PH by25%,
whereas a trend for the opposite effect was seen in progres-
sive PH whether expressed as a ratio of capillaries per
cardiomyocyte or as capillaries per section area (Figure 6A
and 6B). Moreover, a significant interaction between training
status and PH status was present (P0.01). Training had no
effect on capillarization in the LV (Figure IIID of the
online-only Data Supplement).
In progressive PH, clusters of leukocytes were observed in
various parts of the RV myocardium (Figure 7D). As a result,
the number of leukocytes was significantly higher in progres-
sive PH compared with control. Training dramatically in-
creased the RV leukocyte infiltration in progressive PH,
whereas in stable PH, it remained unchanged (Figure 7A).
Moreover, a very significant interaction between training
status and PH status was present (P0.001). Leukocyte
infiltration was observed only in the RV. Analysis of the LV
showed no differences between groups; their values were
even slightly lower than RV control values (Figure 7B).
Discussion
To the best of our knowledge, this is the first study to
investigate the effects of training in stable and progressive
PH, focusing on RV function and remodeling. Using a
comprehensive set of physiological and pathological end
points, we have demonstrated that exercise training was well
tolerated and beneficial in PH with a preserved CO. In this
group, training had no adverse effects on disease progression;
it improved endurance and was associated with enhanced RV
capillarization. However, exercise training was detrimental in
progressive PH developing right heart failure. In this situa-
tion, exercise had adverse effects on hemodynamics and
accelerated the progression to right heart failure. Moreover,
exercise was associated with adverse pulmonary vascular
remodeling and massive RV inflammation.
Functional Improvement After Training
Associated With Enhanced Capillarization
The only prospective clinical trial on exercise training in PH,
by Mereles et al,7 showed that functional capacity and quality
of life of stable PH patients could be improved markedly after
training. The general hemodynamic characteristics of the
subjects in that trial were similar to the stable PH group in our
study; comparable pulmonary artery pressures were found,
together with a mildly depressed cardiac index at rest and
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Figure 5. A, The amount of RV hypertrophy indicated by RV
cross-sectional area (CSA) was similar in stable and progressive
PH. B, RV fibrosis was seen only in progressive PH, and no
(interactive) effect of training was observed. The largest RV
diameters were observed in progressive PH (C), translating into
the highest RV wall stress (D). All data are presented as
meanSEM. EDD indicates end-diastolic diameter. ##P0.01,
###P0.001 vs control; †††P0.001 vs stable PH (P0.001 vs
control).
Figure 6. Training improved RV capillarization in stable PH,
whereas a trend for an opposite effect was observed in progres-
sive PH (capillarization expressed as ratio of capillaries to car-
diomyocytes [A; Cp/Cm] or capillaries per area [B]). Moreover,
a significant interaction between training status and PH status
was present (P0.01). Bottom, Typical examples of RV capillar-
ization (immunofluorescence CD31, 100 magnification) of
control-Sed (C) and stable PH-Ex (D). Green indicates CD31;
red, cardiomyocyte cell membranes. Capillaries can be identi-
fied as green/yellow dots (merging of red and green; arrow). All
data are presented as meanSEM.
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moderate RV dilatation that remained stable during the study
period. In agreement with this clinical study, we found a
marked improvement in exercise endurance in stable PH after
training.
In addition, we found that in stable PH the functional
improvement after training was associated with enhanced
capillarization of the RV. This phenomenon has been de-
scribed for ischemic heart failure,20 and 2 recent studies have
evaluated the effect of training on cardiac angiogenesis in
systemic hypertension.21,22 In spontaneously hypertensive
rats21 and in rats with angiotensin II–induced hypertension,22
exercise was found to improve (LV) capillarization by
40%. This is somewhat higher than the 25% increase in
(RV) capillarization observed in our present study, but the
difference may be explained by the lower training intensity
and shorter exercise period in our study. A direct link
between angiogenesis, hypertrophy, and cardiac function has
been shown.23,24 Insufficient cardiac microvascular growth
was recently identified as an important underlying mecha-
nism in the transition from compensatory hypertrophy to
heart failure.23 Moreover, promotion of cardiac angiogenesis
was found to normalize the relative capillary deficit, to
improve coronary flow reserve, and to restore cardiac dys-
function under chronic pressure overload.24
It is likely that the improved endurance in stable PH is also
partially attributable to other beneficial effects of exercise
that were not studied here. In particular, its effects on skeletal
muscle function in PH deserves further exploration in future
studies because this effect was shown to be relevant in the
rehabilitation of (left) heart failure and chronic obstructive
pulmonary disease patients.25,26
Worsened Survival After Training Associated
With Enhanced RV Inflammation
Traditionally, PH patients were encouraged to limit physical
activity, a view that was based mainly on theoretical argu-
ments.3 Here, we demonstrate that exercise training in pro-
gressive PH can indeed be harmful in the case of a poorly
adapted RV by augmenting pressure overload–associated RV
inflammation.
It is unlikely that RV inflammation is primarily the result
of a direct inflammatory effect of monocrotaline on the
heart.27 We found no evidence for LV inflammation, even in
rats treated with the highest monocrotaline dose. Furthermore,
histology of the RV revealed randomly distributed patches of
infiltration rather than a gradual pattern of inflammatory cells
diffusing from the (sub)endocardium. For these reasons, RV
inflammation in our model is most likely ascribed to chronic RV
pressure overload.
To the best of our knowledge, the link between RV
inflammation and chronic RV pressure overload has not been
investigated yet, neither clinically nor experimentally. How-
ever, in patients suffering from acute pulmonary embolism,
comparable observations of selective RV inflammation were
reported in a postmortem study,18 and similar findings were
observed in experimentally induced acute pulmonary embo-
lism.28 The mechanistic importance of RV inflammation was
demonstrated because suppression of the inflammatory re-
sponse after acute pulmonary embolism limited RV damage
and prevented right heart failure.29 In these studies, it was
suggested that RV inflammation could have been triggered by
ischemic injury of the RV or local and/or systemic overpro-
duction of catecholamines.
High RV wall stress might be an alternative explanation, as
recently shown in a model of chronic LV pressure over-
load.9,30 We observed a similar amount of RV hypertrophy in
all PH groups. However, because of larger RV end-diastolic
diameter, we found the highest RV wall stress in progressive
PH. At resting conditions, RV wall stress was similar in
progressive PH-Ex and progressive PH-Sed. Although we
could not directly measure RV pressures during exercise, RV
afterload probably increased significantly during exercise
because of the elevated PVR.8 Therefore, it is likely that in
progressive PH, RV wall stress was higher during exercise.
These episodes of elevated wall stress could have triggered
RV inflammation because short periods of mechanical stretch
(10 minutes) can induce myocardial overexpression of proin-
flammatory cytokines (like tumor necrosis factor-), which is
followed by leukocyte infiltration.9,30
Finally, training might also directly aggravate preexisting
inflammation in the myocardium. In viral myocarditis, it is
known that exercise augments the inflammatory reaction,
enhances cardiac dilatation, and increases its lethality.31,32
Our study suggests that RV inflammation in PH may be of
pathophysiological importance. Future studies should inves-
tigate its relevance for the different causes of clinical pulmo-
nary arterial hypertension.
Figure 7. A, Training had a dramatic effect on RV leukocyte
infiltration in progressive PH, whereas leukocyte infiltration
remained unchanged in stable PH. Moreover, there was a
strong significant interaction between training status and PH
status (P0.001). B, Inflammation was restricted to the right
ventricle only; values for leukocyte infiltration of LV did not differ
among the experimental groups and were even lower than RV
control values. Bottom, Typical examples of RV leukocyte infil-
tration (immunofluorescence CD45; 100 magnification) of
control-Sed (C) and progressive PH-Ex (D). Green indicates
CD45; blue, nuclei; red, cardiomyocyte cell membranes. Notice
the clustering of aggregated leukocytes in progressive PH-Ex
into the myocardium of the right ventricle. Data are presented
as meanSEM.
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Limitations
The model of PH that was caused by the use of monocrotaline
does not fully replicate the pathophysiology and resulting
pulmonary and cardiovascular effects of clinical PH. There-
fore, this study should be viewed as a seminal analysis of
exercise in stable and progressive PH from which other
(clinical) studies should arise. For example, validated clinical
determinants that can predict a favorable response to exercise
training are currently absent.
The noninvasive estimation of PVR results from several
measurements and is therefore susceptible to a large variabil-
ity. Nevertheless, a close correlation was observed between
echocardiography-derived PVR measurements and histolog-
ical parameters for pulmonary vascular remodeling.
Echocardiography or invasive hemodynamic measure-
ments at the end of the study protocol failed to detect changes
that could explain the differences in survival and endurance
between the trained and sedentary groups. Echocardiography
and invasive hemodynamic measurements, however, were
obtained at rest and therefore do not reflect exercise hemo-
dynamics, which probably differed between both groups.
Moreover, in progressive PH, hemodynamic measurements at
the end of the study protocol were obtained at a stage of
terminal right heart failure, which was, however, reached
earlier in the trained than in the sedentary group. Hence, the
differences in survival between groups are reflected more by
the time elapsed to reach right heart failure than the hemo-
dynamic findings at right heart failure.
Conclusions
In our rat model, exercise training was found to be beneficial
in stable PH but detrimental in progressive PH. The differ-
ential effect is probably due to enhanced RV myocardial
capillarization in stable PH and RV myocardial inflammation
in progressive PH. Future studies are necessary to address the
clinical implications of our findings.
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CLINICAL PERSPECTIVE
The role of exercise training in current clinical management of patients with pulmonary arterial hypertension (PH) remains
controversial. Traditionally, these patients were advised to limit their physical activity because exercise was presumed to
superimpose an additional right ventricular load on an already compromised heart. Recently, exercise training was found
to greatly improve exercise capacity and quality of life in clinically stable PH patients. It remains uncertain, however, if
exercise training is beneficial for all PH patients, including the effects on the right ventricle. Therefore, in the present study,
we studied the effects of exercise training in a rodent model, inducing 2 distinct clinical phenotypes of PH. Training was
found to be beneficial in stable PH with preservation of cardiac function. However, training was detrimental in progressive
PH because it accelerated the progression toward right heart failure and induced widespread right ventricular inflammation.
These findings imply that disease progression and right ventricular adaptation might be important clinical determinants for
favorable response to exercise training in PH. Because clinical PH tends to be a progressive disease, defining “stable” PH
might be challenging. In the absence of prospectively validated criteria, PH patients could be classified as stable when there
is constancy of clinical findings in repeated evaluations over a 3-month period. These findings should include New York
Heart Association classification, 6-minute walk distance, N-terminal prohormone brain natriuretic peptide levels, and right
ventricular function/dimensions. Prospective clinical studies should evaluate these criteria for stable PH to translate the
findings of the present study and to detect PH patients who will benefit from an exercise training program.
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